Which is Most Popular Technology in Cancer/Tumor Profiling Market?

1. Increasing Incidence of Cancer Fueling Cancer/Tumor Profiling Market Growth 1 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

2. From $25.8 billion in 2016, the global cancer/tumor profiling market value is predicted to rise to $87.1 billion by 2023. According to the estimates of the market research organization, P&S Intelligence, the market will demonstrate a CAGR of 19.0% from 2017 to 2023 (forecast period). The major factors propelling the progress of the market are the growing requirement for cancer profiling products, on account of the surging funding being provided for cancer research, soaring prevalence of cancer, burgeoning need for next-generation sequencing, and increasing use of biomarkers in tumor profiling across the world. The growing prevalence of cancer, owing to various factors, such as smoking, changing lifestyles, tobacco consumption, radiation exposure, and eating habits, is one of the major growth drivers of the cancer/tumor profiling market. As per the American Cancer Society, in the U.S., nearly 1,688,780 new cases of cancer were recorded in 2017. Moreover, around 600,920 Americans are predicted to die because of cancer in the coming years, which will propel the mortality rate to 1,650 per day. To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/cancer-profiling- market/report-sample The players operating in the industry are focusing on developing different biomarkers for detecting the existence of cancer cells in the body. For example, Caris Life Sciences has introduced biomarkers based on the next generation sequencing (NGS), in-situ hybridization (ISH), and immunohistochemistry (IHC) technologies to detect the levels of translocations and fusions, protein expression, analyzing amplifications and gene deletion, and detection and examination of DNA mutation, respectively. Biomarkers produced on the basis of fragment analysis assist in detecting the changes in DNA or RNA, which further indicates the absence or presence of genetic markers. For the accurate detection of cancer-causing agents, the usage of biomarkers for cancer profiling is soaring rapidly. Depending on technology, the cancer/tumor profiling market is divided into NGS, quantitative polymerase chain reaction (QPCR), IHC, ISH, and microarray categories. Out of these, the NGS category held the largest share in the market in the past. This was because of the fact that the awareness about NGS products has increased sharply over the last few years, on account of the growing use of NGS products in research laboratories and academic institutions. In the coming years, the NGS category is predicted to demonstrate the highest growth rate in the market. Across the globe, North America contributed the highest revenue to the cancer/tumor profiling market in the years gone by. This was because of rapid technological advancements and innovations in cancer 2 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

3. treatment, increasing research and funding activities, and the existence of major players in the industry. As per the American Cancer Society, nearly 13.0% of the cancer cases that were recorded in geriatric people and adults in 2017 were rare types. Moreover, the incidence of common cancers, such as breast cancer, also surged sharply between 2004 and 2013. These factors significantly pushed up the requirement for cancer/tumor profiling in the region over the past few years. Hence, the demand for cancer/tumor profiling will soar all over the world in the upcoming years, primarily because of the rising prevalence of cancer and mushrooming geriatric population. The research offers market size of the cancer/tumor profiling for the period 2013–2023. GLOBAL CANCER/TUMOR PROFILING MARKET, BY TECHNOLOGY  Next generation sequencing (NGS) oBy region  Quantitative polymerase chain reaction (QPCR) oBy region  Immunohistochemistry (IHC) oBy region  In-situ hybridization (ISH) oBy type Fluorescent in situ hybridization (FISH) Chromogenic in situ hybridization (CISH)   oBy region  Microarray oBy region GLOBAL CANCER/TUMOR PROFILING MARKET, BY TECHNIQUE  Genomics oBy region  Proteomics oBy region  Epigenetics oBy region  Metabolomics oBy region 3 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

4. GLOBAL CANCER/TUMOR PROFILING MARKET, BY APPLICATION  Personalized medicine oBy region  Diagnostics oBy region  Biomarker discovery oBy region  Prognostics oBy region GLOBAL CANCER/TUMOR PROFILING MARKET, BY GEOGRAPHY North America cancer/tumor profiling market  By technology By technique By application By country - The U.S. and Canada    Europe cancer/tumor profiling market  By technology By technique By application By country - Germany, U.K., France, and Rest of Europe    Asia-Pacific cancer/tumor profiling market  By technology By technique By application By country - Japan, China, and Rest of Asia-Pacific    Latin America (LATAM) cancer/tumor profiling market  By technology By technique By application   4 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

5. By country - Brazil, Mexico and Rest of LATAM  Middle East & Africa (MEA) cancer/tumor profiling market  By technology By technique By application   5 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

6. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 6 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved